Skip to main content


Higher blood sugar levels cause damage over time to blood vessels and nerves, which can affect your eyes, heart, kidneys, and other organs. It’s important to be aware of these diabetes-related health complications so that you can act now to avoid them or prevent them from progressing.

Our overview of what all of us need to know about one of our most vital organs – our kidneys.
Current trial results show that obese patients using Contrave are about 41% less likely to experience any major heart event (e.g. heart attack, strokes, or heart-related...
Combining metformin and Jardiance into a single pill.
Breaking news from Stockholm, Sweden, where our team is on the ground at the European Association for the Study of Diabetes (EASD) Conference – one of the largest...
A 38% decrease in cardiovascular death is exciting, but our work is nowhere near done.
Leaders in diabetes weigh in at The diaTribe Foundation’s second-annual event in Europe.
New two-year study suggests red wine is beneficial for cholesterol levels.
Transforming patient stories into an inspirational theater program across the US.
Leading ophthalmologist Dr. Ivan Suñer on what diabetic retinopathy is, how to prevent it, and what future treatments hold.
Paving the way to healthier food options and preventing heart disease.
Behavioral expert Dr. Bill Polonsky on how providers and caregivers can reframe diabetes conversations.
At the Children with Diabetes Friends for Life Conference this month, I had the incredible opportunity to speak to ~100 teenagers with diabetes. My talk, “10 Tips for...
Two new large studies investigate Finerenone in type 2 diabetes.
Intarcia just announced exciting results for ITCA 650 , a small implanted device to treat type 2 diabetes. The tiny device is implanted under the skin just once or twice...
How do the trends compare to childhood type 2 diabetes?
Today, Lilly/BI announced first-ever news in diabetes: a major clinical trial on Jardiance , an SGLT-2 inhibitor pill for type 2 diabetes, has been proven to improve...
Five patients share their experiences with the FDA-cleared, no-prescription-needed device. What did they like and how can it be made even better?
Key lessons learned from one woman’s ongoing battle with adrenal insufficiency, and the unexpected role of diabetes technology.
New improvements in the second-generation: better battery, app control, and more!
Enrolling at over 140 sites worldwide. Can it reduce A1c and insulin use and improve time-in-range?